Jove
Visualize
Contact Us

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brighter days ahead: the shifting landscape of IBD therapy.

Current opinion in gastroenterology·2025
Same author

Characteristics of Immune Checkpoint Inhibitor-Associated Gastritis: Report from a Major Tertiary Care Center.

The oncologist·2023
Same author

Patients and physicians' attitudes change on fecal microbiota transplantation for inflammatory bowel disease over the past 3 years.

Annals of translational medicine·2021
Same author

The role of the transition clinic from pediatric to adult inflammatory bowel disease care.

Current opinion in gastroenterology·2019
Same author

Vedolizumab in the treatment of Crohn's disease of the pouch.

Gastroenterology report·2018
Same author

Challenges in Transitional Care in Inflammatory Bowel Disease: A Review of the Current Literature in Transition Readiness and Outcomes.

Inflammatory bowel diseases·2018
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 4, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

Transitional care in inflammatory bowel disease.

Jessica R Philpott1

  • 1Division of Digestive Diseases at the University of Oklahoma in Oklahoma City, Oklahoma, USA. Jessica-philpott@ouhsc.edu

Gastroenterology & Hepatology
|February 25, 2011
PubMed
Summary
This summary is machine-generated.

Transitional care helps pediatric patients manage chronic conditions like inflammatory bowel disease (IBD) as they move to adult healthcare. More research is needed on effective transition programs for adolescents and young adults with IBD.

Keywords:
Adolescent healthcareinflammatory bowel diseasepediatricstransition to adult medicine

More Related Videos

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

Related Experiment Videos

Last Updated: Jun 4, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

Area of Science:

  • Pediatric Gastroenterology
  • Healthcare Transition
  • Chronic Disease Management

Background:

  • Transitional care supports pediatric patients in assuming self-care responsibility and transferring to adult practitioners.
  • Inflammatory bowel disease (IBD) is a chronic condition often diagnosed in childhood, making transitional care crucial for adolescents and young adults.
  • Existing recommendations for transitional care lack robust evidence regarding optimal protocols and program efficacy, especially for IBD.

Purpose of the Study:

  • To highlight the importance of transitional care for pediatric patients with chronic diseases, particularly inflammatory bowel disease (IBD).
  • To identify current recommendations and knowledge gaps in the implementation and efficacy of transitional care programs for IBD.
  • To emphasize the need for future research to determine effective transitional care strategies.

Main Methods:

  • Review of existing literature and guidelines on transitional care for chronic diseases.
  • Analysis of the specific challenges and needs of adolescent and young adult IBD patients during healthcare transitions.
  • Identification of key components of effective transitional care, including education, early introduction to adult care, and communication.

Main Results:

  • Transitional care is recognized as vital for chronic conditions diagnosed in childhood, including IBD.
  • There is a significant lack of empirical data on the optimal delivery and effectiveness of transitional care programs for IBD.
  • Current guidelines emphasize patient education, early transfer planning, and inter-provider communication.

Conclusions:

  • Effective transitional care programs are essential for improving long-term outcomes in young adults with IBD.
  • Further research is critically needed to establish evidence-based protocols for transitional care in IBD.
  • Elucidating the most effective program models and implementation strategies is a priority for future studies.